Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Stress-induced impairments in prefrontal-mediated behaviors and the role of the N-methyl-D-aspartate receptor.

Graybeal C, Kiselycznyk C, Holmes A.

Neuroscience. 2012 Jun 1;211:28-38. doi: 10.1016/j.neuroscience.2012.02.042. Epub 2012 Feb 28. Review.

2.

Stress-induced prefrontal reorganization and executive dysfunction in rodents.

Holmes A, Wellman CL.

Neurosci Biobehav Rev. 2009 Jun;33(6):773-83. doi: 10.1016/j.neubiorev.2008.11.005. Epub 2008 Dec 6. Review.

3.

The effect of non-competitive NMDA receptor antagonist MK-801 on neuronal activity in rodent prefrontal cortex: an animal model for cognitive symptoms of schizophrenia.

Blot K, Bai J, Otani S.

J Physiol Paris. 2013 Dec;107(6):448-51. doi: 10.1016/j.jphysparis.2013.04.003. Epub 2013 Apr 18. Review.

PMID:
23603055
4.

Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations.

Lewis DA, Moghaddam B.

Arch Neurol. 2006 Oct;63(10):1372-6. Review.

PMID:
17030651
5.

Stress weakens prefrontal networks: molecular insults to higher cognition.

Arnsten AF.

Nat Neurosci. 2015 Oct;18(10):1376-85. doi: 10.1038/nn.4087. Epub 2015 Sep 25. Review.

6.
7.

Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction.

Goldman-Rakic PS, Castner SA, Svensson TH, Siever LJ, Williams GV.

Psychopharmacology (Berl). 2004 Jun;174(1):3-16. Epub 2004 Apr 30. Review.

PMID:
15118803
8.

[Executive functioning in unipolar depression: a review].

Fossati P, Ergis AM, Allilaire JF.

Encephale. 2002 Mar-Apr;28(2):97-107. Review. French.

PMID:
11972136
9.

Stress-induced deficits in cognition and emotionality: a role of glutamate.

Graybeal C, Kiselycznyk C, Holmes A.

Curr Top Behav Neurosci. 2012;12:189-207. Review.

10.

Pathophysiologically based treatment interventions in schizophrenia.

Lewis DA, Gonzalez-Burgos G.

Nat Med. 2006 Sep;12(9):1016-22. Review.

PMID:
16960576
11.
12.

Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in Schizophrenia.

Wonodi I, Schwarcz R.

Schizophr Bull. 2010 Mar;36(2):211-8. doi: 10.1093/schbul/sbq002. Epub 2010 Feb 10. Review.

13.

A computational approach to prefrontal cortex, cognitive control and schizophrenia: recent developments and current challenges.

Cohen JD, Braver TS, O'Reilly RC.

Philos Trans R Soc Lond B Biol Sci. 1996 Oct 29;351(1346):1515-27. Review.

PMID:
8941963
14.

Pharmacological enhancement of memory and executive functioning in laboratory animals.

Floresco SB, Jentsch JD.

Neuropsychopharmacology. 2011 Jan;36(1):227-50. doi: 10.1038/npp.2010.158. Epub 2010 Sep 15. Review.

15.

The brain on stress: vulnerability and plasticity of the prefrontal cortex over the life course.

McEwen BS, Morrison JH.

Neuron. 2013 Jul 10;79(1):16-29. doi: 10.1016/j.neuron.2013.06.028. Review.

16.

Molecular basis of pharmacotherapies for cognition in Down syndrome.

Gardiner KJ.

Trends Pharmacol Sci. 2010 Feb;31(2):66-73. doi: 10.1016/j.tips.2009.10.010. Epub 2009 Dec 4. Review.

17.

Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia.

Javitt DC, Zukin SR, Heresco-Levy U, Umbricht D.

Schizophr Bull. 2012 Sep;38(5):958-66. doi: 10.1093/schbul/sbs069. Review.

18.

Guanfacine for the treatment of cognitive disorders: a century of discoveries at Yale.

Arnsten AF, Jin LE.

Yale J Biol Med. 2012 Mar;85(1):45-58. Epub 2012 Mar 29. Review.

19.

[Cognition, schizophrenia and the effect of antipsychotics].

Stip E.

Encephale. 2006 May-Jun;32(3 Pt 1):341-50. Review. French.

PMID:
16840928
20.
Items per page

Supplemental Content

Write to the Help Desk